Skip to main content

 Related scientific articles (all)

Multicenter Harmonization of 89Zr PET/CT Performance.

Authors : Makris NE, Boellaard R, Visser EP, de Jong JR, Vanderlinden B, Wierts R, van der Veen BJ, Greuter HJ, Vugts DJ, van Dongen GA, Lammertsma AA, Huisman MC
Year : 2014
Journal : J. Nucl. Med.
Volume : 55(2)
Pages : 264-7

Reply to Letter re: General Theory of Predictive Dosimetry for Yttrium-90 Radioembolization to Sites Other Than the Liver.

Authors : Muylle K, Vanderlinden B
Year : 2014
Journal : Cardiovasc Intervent Radiol
Volume : 37(4)
Pages : 1118-19

Reproducibility of lymphoscintigraphic evaluation of the upper limb.

Authors : Devoogdt N, Van den Wyngaert T, Bourgeois P, Lambrechts M, Van Kampen M, De Groef A, Geraerts I, Neven P, Vergote I, Tjalma W, Christiaens MR, Stroobants S
Year : 2014
Journal : Lymphat Res Biol
Volume : 12(3)
Pages : 175-84

Short time effects of radiotherapy on lymphatic vessels and restorative lymphatic pathways: experimental approaches ina mouse model.

Authors : Pastouret F, Lievens P, Leduc O, Bourgeois P, Tournel K, Lamote J, Zirak C, Leduc A
Year : 2014
Journal : Lymphology
Volume : 47(2)
Pages : 92-100

Case Report: Mammary and rectal metastases from an ovarian cancer: report of two cases and review of literature

Authors : Amzerin M, Garcia C, Stanciu C, Veys I, Awada A, Errihani H, Gombos A
Year : 2014
Journal : F1000Res
Volume : 3
Pages : 255

Optimizing the use of PET with selective internal radiation therapy.

Authors : Flamen P
Year : 2014
Journal : Future Oncol
Volume : 10(15 Suppl)
Pages : 73-5

Tribute to Professor Jacques Henry(1921-2014).

Authors : Frühling J, Van Houtte P
Year : 2014
Journal : Rev Med Brux
Volume : 35(3)
Pages : 189-90

18F-FDG PET/CT for Early Prediction of Response to Neoadjuvant Lapatinib, Trastuzumab, and Their Combination in HER2-Positive Breast Cancer: Results from Neo-ALTTO.

Authors : Gebhart G, Gámez C, Holmes E, Robles J, Garcia C, Cortés M, de Azambuja E, Fauria K, van Dooren V, Aktan G, Coccia-Portugal MA, Kim SB, Vuylsteke P, Cure H, Eidtmann H, Baselga J, Piccart-Gebhart M, Flamen P, Di Cosimo S
Year : 2013
Journal : J. Nucl. Med.
Volume : 54(11)
Pages : 1862-8

Circulating tumor cells and response to neoadjuvant paclitaxel and HER2-targeted therapy: A sub-study from the NeoALTTO phase III trial.

Authors : Azim HA, Rothé F, Aura CM, Bavington M, Maetens M, Rouas G, Gebhart G, Gamez C, Eidtmann H, Baselga J, Piccart-Gebhart M, Ellis C, Vuylsteke P, Cure H, Domont J, Ferro A, Toral-Peña JC, de Azambuja E, Sotiriou C, Di Cosimo S, Ignatiadis M
Year : 2013
Journal : Breast
Volume : 22(6)
Pages : 1060-5

Role and interpretation of fluorodeoxyglucose-positron emission tomography/computed tomography in HIV-infected patients with fever of unknown origin: a prospective study.

Authors : Martin C, Castaigne C, Tondeur M, Flamen P, De Wit S
Year : 2013
Journal : HIV Med
Volume : 14(8)
Pages : 455-62

Planning cancer control in Latin America and the Caribbean.

Authors : Goss PE, Lee BL, Badovinac-Crnjevic T, Strasser-Weippl K, Chavarri-Guerra Y, Louis JS, Villarreal-Garza C, Unger-Saldaña K, Ferreyra M, Debiasi M, Liedke PE, Touya D, Werutsky G, Higgins M, Fan L, Vasconcelos C, Cazap E, Vallejos C, Mohar A, Knaul F, Arreola H, Batura R, Luciani S, Sullivan R, Finkelstein D, Simon S, Barrios C, Kightlinger R, Gelrud A, Bychkovsky V, Lopes G, Stefani S, Blaya M, Souza FH, Santos FS, Kaemmerer A, de Azambuja E, Zorilla AF, Murillo R, Jeronimo J, Tsu V, Carvalho A, Gil CF, Sternberg C, Dueñas-Gonzalez A, Sgroi D, Cuello M, Fresco R, Reis RM, Masera G, Gabús R, Ribeiro R, Knust R, Ismael G, Rosenblatt E, Roth B, Villa L, Solares AL, Leon MX, Torres-Vigil I, Covarrubias-Gomez A, Hernández A, Bertolino M, Schwartsmann G, Santillana S, Esteva F, Fein L, Mano M, Gomez H, Hurlbert M, Durstine A, Azenha G
Year : 2013
Journal : Lancet Oncol
Volume : 14(5)
Pages : 391-436

Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): Protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study.

Authors : Hendlisz A, Golfinopoulos V, Deleporte A, Paesmans M, Mansy H, Garcia C, Peeters M, Annemans L, Vandeputte C, Maetens M, Borbath I, Dresse D, Houbier G, Fried M, Awada A, Piccart-Gebhart M, Laethem JL, Flamen P
Year : 2013
Journal : BMC Cancer
Volume : 13(1)
Pages : 190

Comparison of PET metabolic indices for the early assessment of tumour response in metastatic colorectal cancer patients treated by polychemotherapy.

Authors : Maisonobe JA, Garcia C, Necib H, Vanderlinden B, Hendlisz A, Flamen P, Buvat I
Year : 2013
Journal : Eur J Nucl Med Mol Imaging
Volume : 40(2)
Pages : 166-74

Radioembolization of the Spleen: A Revisited Approach for the Treatment of Malignant Lymphomatous Splenomegaly. (epub online 2012)

Authors : Muylle K, Nguyen J, de Wind A, Meuleman N, Delatte P, Vanderlinden B, Roelandts M, Vanderstappen A, Bron D, Flamen P
Year : 2013
Journal : Cardiovasc Intervent Radiol
Volume : 36(4)
Pages : 1155-60

Histiocytose agressive à cellules de Langerhans 20 ans après un cancer du sein : à propos d’un cas.

Authors : Zakkouri F, Klastersky J, Alexiou J, de Saint-Aubain de Somerhausen N, Flamen P, Firescu R, Georgala A, Awada A
Year : 2013
Journal : J Am Soc Echocardiogr
Volume : 5
Pages : 220-223

Contributions of SPECT/CT imaging to the lymphoscintigraphic investigations of the lower limb lymphedema.

Authors : Baulieu F, Bourgeois P, Maruani A, Belgrado JP, Tauveron V, Lorette G, Vaillant L
Year : 2013
Journal : Lymphology
Volume : 46(3)
Pages : 106-19

Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations.

Authors : Berghmans T, Pasleau F, Paesmans M, Bonduelle Y, Cadranel J, CsToth I, Garcia C, Giner V, Holbrechts S, Lafitte JJ, Lecomte J, Louviaux I, Markiewicz E, Meert AP, Richez M, Roelandts M, Scherpereel A, Tulippe Ch, Van Houtte P, van Schil P, Wachters C, Westeel V, Sculier JP
Year : 2012
Journal : Eur. Respir. J.
Volume : 39(1)
Pages : 9-28

Serial FDG-PET/CT for early outcome prediction in patients with metastatic colorectal cancer undergoing chemotherapy.

Authors : Hendlisz A, Golfinopoulos V, Garcia C, Covas A, Emonts P, Ameye L, Paesmans M, Deleporte A, Machiels G, Toussaint E, Vanderlinden B, Awada A, Piccart-Gebhart M, Flamen P
Year : 2012
Journal : Ann Oncol
Volume : 23(7)
Pages : 1687-93

Safety and Efficacy of Radioimmunotherapy with 90Yttrium-rituximab in Patients with Relapsed CD20+ B cell Lymphoma: A Feasibility Study

Authors : Vaes M, Bron D, Vugts DJ, Paesmans M, Meuleman N, Ghanem G, Vanderlinden B, Thielemans K, van Dongen GA, Flamen P, Muylle K
Year : 2012
Journal : J Cancer Sci Ther
Volume : 4(12)
Pages : 394-400

Radiothérapie intra-opératoire et cancer du sein

Authors : Philippson C, Nogaret JM, Simon S
Year : 2012
Journal : Hospitals.be
Volume : 1
Pages : 7-11